SEC Form 4 · accession 0001144204-16-111502
KIORA PHARMACEUTICALS INC · KPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen From
Officer — President and CEO · Director
Period of report
Jun 30, 2016
Accepted (ET)
Jul 5, 2016 · 4:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001372514
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 30, 2016 | M | 52,990 | $0.6478 | A | 124,965 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.6478 | Jun 30, 2016 | M | 52,990 | D | — | Jul 25, 2016 | Common Stock | 52,990 | 0 | D |
Explanation of responses
- F1The Reporting Person was granted an option to purchase these shares pursuant to the Issuer's 2005 Equity Incentive Plan. Each option became exercisable immediately upon grant.